1 Introduction to Research & Analysis Reports |
|
1.1 Vinorelbine Market Definition |
|
1.2 Market Segments |
|
| 1.2.1 Segment by Type | |
| 1.2.2 Segment by Application | |
1.3 China Vinorelbine Market Overview |
|
1.4 Methodology & Sources of Information |
|
| 1.4.1 Research Methodology | |
| 1.4.2 Research Process | |
| 1.4.3 Base Year | |
2 China Vinorelbine Overall Market Size |
|
2.1 China Vinorelbine Market Size: 2021 VS 2027 |
|
2.2 China Vinorelbine Revenue, Prospects & Forecasts: 2016-2027 |
|
2.3 China Vinorelbine Sales: 2016-2027 |
|
3 Company Landscape |
|
3.1 Top Vinorelbine Players in China Market |
|
3.2 Top China Vinorelbine Companies Ranked by Revenue |
|
3.3 China Vinorelbine Revenue by Companies |
|
3.4 China Vinorelbine Sales by Companies |
|
3.5 China Vinorelbine Price by Manufacturer (2016-2021) |
|
3.6 Top 3 and Top 5 Vinorelbine Companies in China Market, by Revenue in 2020 |
|
3.7 Manufacturers Vinorelbine Product Type |
|
3.8 Tier 1, Tier 2 and Tier 3 Vinorelbine Players in China Market |
|
| 3.8.1 List of Tier 1 Vinorelbine Companies in China | |
| 3.8.2 List of Tier 2 and Tier 3 Vinorelbine Companies in China | |
4 Sights by Type |
|
4.1 Overview |
|
| 4.1.1 By Type - China Vinorelbine Market Size Markets, 2021 & 2027 | |
| 4.1.2 Oral | |
| 4.1.3 Injection | |
4.2 By Type - China Vinorelbine Revenue & Forecasts |
|
| 4.2.1 By Type - China Vinorelbine Revenue, 2016-2021 | |
| 4.2.2 By Type - China Vinorelbine Revenue, 2022-2027 | |
| 4.2.3 By Type - China Vinorelbine Revenue Market Share, 2016-2027 | |
4.3 By Type - China Vinorelbine Sales & Forecasts |
|
| 4.3.1 By Type - China Vinorelbine Sales, 2016-2021 | |
| 4.3.2 By Type - China Vinorelbine Sales, 2022-2027 | |
| 4.3.3 By Type - China Vinorelbine Sales Market Share, 2016-2027 | |
| 全^文：http://www.hczzz.cn/6/29/China-Vinorelbine-Market-In-Depth-Research-and-Trends-Analysis-Report-2022-2027.html | |
4.4 By Type - China Vinorelbine Price (Manufacturers Selling Prices), 2016-2027 |
|
5 Sights by Application |
|
5.1 Overview |
|
| 5.1.1 By Application - China Vinorelbine Market Size, 2021 & 2027 | |
| 5.1.2 Breast Cancer | |
| 5.1.3 Non-small Cell Lung Cancer | |
| 5.1.4 Other | |
5.2 By Application - China Vinorelbine Revenue & Forecasts |
|
| 5.2.1 By Application - China Vinorelbine Revenue, 2016-2021 | |
| 5.2.2 By Application - China Vinorelbine Revenue, 2022-2027 | |
| 5.2.3 By Application - China Vinorelbine Revenue Market Share, 2016-2027 | |
5.3 By Application - China Vinorelbine Sales & Forecasts |
|
| 5.3.1 By Application - China Vinorelbine Sales, 2016-2021 | |
| 5.3.2 By Application - China Vinorelbine Sales, 2022-2027 | |
| 5.3.3 By Application - China Vinorelbine Sales Market Share, 2016-2027 | |
5.4 By Application - China Vinorelbine Price (Manufacturers Selling Prices), 2016-2027 |
|
6 Manufacturers & Brands Profiles |
|
6.1 Pierre Fabre Pharmaceuticals, Inc. |
|
| 6.1.1 Pierre Fabre Pharmaceuticals, Inc. Corporation Information | |
| 6.1.2 Pierre Fabre Pharmaceuticals, Inc. Overview | |
| 6.1.3 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.1.4 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Product Description | |
| 6.1.5 Pierre Fabre Pharmaceuticals, Inc. Recent Developments | |
6.2 TEVA Pharms |
|
| 6.2.1 TEVA Pharms Corporation Information | |
| 6.2.2 TEVA Pharms Overview | |
| 6.2.3 TEVA Pharms Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.2.4 TEVA Pharms Vinorelbine Product Description | |
| 6.2.5 TEVA Pharms Recent Developments | |
6.3 Hospira, Inc. |
|
| 6.3.1 Hospira, Inc. Corporation Information | |
| 6.3.2 Hospira, Inc. Overview | |
| 6.3.3 Hospira, Inc. Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.3.4 Hospira, Inc. Vinorelbine Product Description | |
| 6.3.5 Hospira, Inc. Recent Developments | |
6.4 West-Ward Pharmaceuticals Corp. |
|
| 6.4.1 West-Ward Pharmaceuticals Corp. Corporation Information | |
| 6.4.2 West-Ward Pharmaceuticals Corp. Overview | |
| 6.4.3 West-Ward Pharmaceuticals Corp. Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.4.4 West-Ward Pharmaceuticals Corp. Vinorelbine Product Description | |
| 6.4.5 West-Ward Pharmaceuticals Corp. Recent Developments | |
6.5 Fresenius Kabi |
|
| 6.5.1 Fresenius Kabi Corporation Information | |
| 6.5.2 Fresenius Kabi Overview | |
| 6.5.3 Fresenius Kabi Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.5.4 Fresenius Kabi Vinorelbine Product Description | |
| 6.5.5 Fresenius Kabi Recent Developments | |
6.6 EBEWE Pharma (Sandoz A Novartis Division) |
|
| 6.6.1 EBEWE Pharma (Sandoz A Novartis Division) Corporation Information | |
| 6.6.2 EBEWE Pharma (Sandoz A Novartis Division) Overview | |
| 6.6.3 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.6.4 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Product Description | |
| 6.6.5 EBEWE Pharma (Sandoz A Novartis Division) Recent Developments | |
6.7 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
|
| 6.7.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Corporation Information | |
| 6.7.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Overview | |
| 6.7.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.7.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Product Description | |
| 6.7.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments | |
6.8 Mylan |
|
| 6.8.1 Mylan Corporation Information | |
| 6.8.2 Mylan Overview | |
| 6.8.3 Mylan Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.8.4 Mylan Vinorelbine Product Description | |
| 6.8.5 Mylan Recent Developments | |
6.9 Dr. Reddy's Laboratories |
|
| 6.9.1 Dr. Reddy's Laboratories Corporation Information | |
| 6.9.2 Dr. Reddy's Laboratories Overview | |
| 6.9.3 Dr. Reddy's Laboratories Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.9.4 Dr. Reddy's Laboratories Vinorelbine Product Description | |
| 6.9.5 Dr. Reddy's Laboratories Recent Developments | |
6.10 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. |
|
| 6.10.1 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Corporation Information | |
| 6.10.2 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Overview | |
| 6.10.3 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.10.4 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Product Description | |
| 2022-2027年中國(guó)長(zhǎng)春瑞濱市場(chǎng)深度研究與趨勢(shì)分析報(bào)告 | |
| 6.10.5 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Recent Developments | |
6.11 Nanjing Cuccess Pharmaceutical Co., Ltd |
|
| 6.11.1 Nanjing Cuccess Pharmaceutical Co., Ltd Corporation Information | |
| 6.11.2 Nanjing Cuccess Pharmaceutical Co., Ltd Overview | |
| 6.11.3 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.11.4 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Product Description | |
| 6.11.5 Nanjing Cuccess Pharmaceutical Co., Ltd Recent Developments | |
6.12 Qilu Pharmaceutical (Hainan) Co., Ltd. |
|
| 6.12.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Corporation Information | |
| 6.12.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Overview | |
| 6.12.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.12.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Product Description | |
| 6.12.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments | |
6.13 Sinopharm A-Think Pharmaceutical Co., Ltd. |
|
| 6.13.1 Sinopharm A-Think Pharmaceutical Co., Ltd. Corporation Information | |
| 6.13.2 Sinopharm A-Think Pharmaceutical Co., Ltd. Overview | |
| 6.13.3 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.13.4 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Product Description | |
| 6.13.5 Sinopharm A-Think Pharmaceutical Co., Ltd. Recent Developments | |
6.14 Beijing SL Pharm |
|
| 6.14.1 Beijing SL Pharm Corporation Information | |
| 6.14.2 Beijing SL Pharm Overview | |
| 6.14.3 Beijing SL Pharm Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.14.4 Beijing SL Pharm Vinorelbine Product Description | |
| 6.14.5 Beijing SL Pharm Recent Developments | |
6.15 Shenzhen Main Luck Pharmaceuticals Inc. |
|
| 6.15.1 Shenzhen Main Luck Pharmaceuticals Inc. Corporation Information | |
| 6.15.2 Shenzhen Main Luck Pharmaceuticals Inc. Overview | |
| 6.15.3 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.15.4 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Product Description | |
| 6.15.5 Shenzhen Main Luck Pharmaceuticals Inc. Recent Developments | |
6.16 Shanxi Powerdone Pharmaceutics Co., Ltd. |
|
| 6.16.1 Shanxi Powerdone Pharmaceutics Co., Ltd. Corporation Information | |
| 6.16.2 Shanxi Powerdone Pharmaceutics Co., Ltd. Overview | |
| 6.16.3 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.16.4 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Product Description | |
| 6.16.5 Shanxi Powerdone Pharmaceutics Co., Ltd. Recent Developments | |
6.17 Luoxin Pharmaceutical Group Co., Ltd. |
|
| 6.17.1 Luoxin Pharmaceutical Group Co., Ltd. Corporation Information | |
| 6.17.2 Luoxin Pharmaceutical Group Co., Ltd. Overview | |
| 6.17.3 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales and Revenue in China Market (2016-2021) | |
| 6.17.4 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Product Description | |
| 6.17.5 Luoxin Pharmaceutical Group Co., Ltd. Recent Developments | |
7 China Vinorelbine Production Capacity, Analysis |
|
7.1 China Vinorelbine Production Capacity, 2016-2027 |
|
7.2 Vinorelbine Production Capacity of Key Manufacturers in China Market |
|
8 Key Market Trends, Opportunity, Drivers and Restraints |
|
8.1 Market Opportunities & Trends |
|
8.2 Market Drivers |
|
8.3 Market Restraints |
|
9 Vinorelbine Supply Chain Analysis |
|
9.1 Vinorelbine Industry Value Chain |
|
9.2 Vinorelbine Upstream Market |
|
9.3 Vinorelbine Downstream and Clients |
|
9.4 Marketing Channels Analysis |
|
| 9.4.1 Marketing Channels | |
| 9.4.2 Vinorelbine Distributors and Sales Agents in China Market | |
10 Conclusion |
|
11 Appendix |
|
11.1 Note |
|
11.2 Examples of Clients |
|
11.3 Author Details |
|
11.4 Disclaimer |
|
| Vinorelbine is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. | |
| This report contains market size and forecasts of Vinorelbine in China, including the following market information: | |
| China Vinorelbine Market Revenue, 2016-2021, 2022-2027, ($ millions) | |
| China Vinorelbine Market Sales, 2016-2021, 2022-2027, (MT) | |
| China top five Vinorelbine companies in 2020 (%) | |
| The global Vinorelbine market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027. | |
| The China Vinorelbine market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period. | |
| has surveyed the Vinorelbine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. | |
| Total Market by Segment: | |
| China Vinorelbine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT) | |
| 2022-2027年中國(guó)長(zhǎng)春瑞濱市場(chǎng)深度研究與趨勢(shì)分析報(bào)告 | |
| China Vinorelbine Market Segment Percentages, By Type, 2020 (%) | |
| Oral | |
| Injection | |
| China Vinorelbine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT) | |
| China Vinorelbine Market Segment Percentages, By Application, 2020 (%) | |
| Breast Cancer | |
| Non-small Cell Lung Cancer | |
| Other | |
| Competitor Analysis | |
| The report also provides analysis of leading market participants including: | |
| Key companies Vinorelbine revenues in China market, 2016-2021 (Estimated), ($ millions) | |
| Key companies Vinorelbine revenues share in China market, 2020 (%) | |
| Key companies Vinorelbine sales in China market, 2016-2021 (Estimated), (MT) | |
| Key companies Vinorelbine sales share in China market, 2020 (%) | |
| Further, the report presents profiles of competitors in the market, key players include: | |
| Pierre Fabre Pharmaceuticals, Inc. | |
| TEVA Pharms | |
| Hospira, Inc. | |
| West-Ward Pharmaceuticals Corp. | |
| Fresenius Kabi | |
| EBEWE Pharma (Sandoz A Novartis Division) | |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | |
| Mylan | |
| Dr. Reddy's Laboratories | |
| Hangzhou Minsheng Pharmaceutical Group Co., Ltd. | |
| Nanjing Cuccess Pharmaceutical Co., Ltd | |
| Qilu Pharmaceutical (Hainan) Co., Ltd. | |
| Sinopharm A-Think Pharmaceutical Co., Ltd. | |
| Beijing SL Pharm | |
| Shenzhen Main Luck Pharmaceuticals Inc. | |
| Shanxi Powerdone Pharmaceutics Co., Ltd. | |
| Luoxin Pharmaceutical Group Co., Ltd. | |
| List of Tables | |
| Table 1. Key Players of Vinorelbine in China Market | |
| Table 2. Top Vinorelbine Players in China Market, Ranking by Revenue (2019) | |
| Table 3. China Vinorelbine Revenue by Companies, (US$, Mn), 2016-2021 | |
| Table 4. China Vinorelbine Revenue Share by Companies, 2016-2021 | |
| Table 5. China Vinorelbine Sales by Companies, (MT), 2016-2021 | |
| Table 6. China Vinorelbine Sales Share by Companies, 2016-2021 | |
| Table 7. Key Manufacturers Vinorelbine Price (2016-2021) & (USD/Kg) | |
| Table 8. Manufacturers Vinorelbine Product Type | |
| Table 9. List of Tier 1 Vinorelbine Companies, Revenue (US$, Mn) in 2020 and Market Share | |
| Table 10. List of Tier 2 and Tier 3 Vinorelbine Companies, Revenue (US$, Mn) in 2020 and Market Share | |
| Table 11. Major Manufacturers of Oral | |
| Table 12. Major Manufacturers of Injection | |
| Table 13. By Type – China Vinorelbine Revenue, (US$, Mn), 2021 & 2027 | |
| Table 14. By Type - China Vinorelbine Revenue (US$, Mn), 2016-2021 | |
| Table 15. By Type - China Vinorelbine Revenue (US$, Mn), 2022-2027 | |
| Table 16. By Type - China Vinorelbine Sales (MT), 2016-2021 | |
| Table 17. By Type - China Vinorelbine Sales (MT), 2022-2027 | |
| Table 18. By Application – China Vinorelbine Revenue, (US$, Mn), 2021 VS 2027 | |
| Table 19. By Application - China Vinorelbine Revenue (US$, Mn), 2016-2021 | |
| Table 20. By Application - China Vinorelbine Revenue (US$, Mn), 2022-2027 | |
| Table 21. By Application - China Vinorelbine Sales (MT), 2016-2021 | |
| Table 22. By Application - China Vinorelbine Sales (MT), 2022-2027 | |
| Table 23. Pierre Fabre Pharmaceuticals, Inc. Corporation Information | |
| Table 24. Pierre Fabre Pharmaceuticals, Inc. Description and Major Businesses | |
| Table 25. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 26. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Product | |
| Table 27. Pierre Fabre Pharmaceuticals, Inc. Recent Developments | |
| Table 28. TEVA Pharms Corporation Information | |
| Table 29. TEVA Pharms Description and Major Businesses | |
| Table 30. TEVA Pharms Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 31. TEVA Pharms Vinorelbine Product | |
| Table 32. TEVA Pharms Recent Developments | |
| Table 33. Hospira, Inc. Corporation Information | |
| Table 34. Hospira, Inc. Description and Major Businesses | |
| Table 35. Hospira, Inc. Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 36. Hospira, Inc. Vinorelbine Product | |
| Table 37. Hospira, Inc. Recent Developments | |
| Table 38. West-Ward Pharmaceuticals Corp. Corporation Information | |
| Table 39. West-Ward Pharmaceuticals Corp. Description and Major Businesses | |
| Table 40. West-Ward Pharmaceuticals Corp. Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 41. West-Ward Pharmaceuticals Corp. Vinorelbine Product | |
| Table 42. West-Ward Pharmaceuticals Corp. Recent Developments | |
| 2022-2027 Nian Zhong Guo Chang Chun Rui Bin Shi Chang ShenDu YanJiu Yu Qu Shi FenXi Bao Gao | |
| Table 43. Fresenius Kabi Corporation Information | |
| Table 44. Fresenius Kabi Description and Major Businesses | |
| Table 45. Fresenius Kabi Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 46. Fresenius Kabi Vinorelbine Product | |
| Table 47. Fresenius Kabi Recent Developments | |
| Table 48. EBEWE Pharma (Sandoz A Novartis Division) Corporation Information | |
| Table 49. EBEWE Pharma (Sandoz A Novartis Division) Description and Major Businesses | |
| Table 50. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 51. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Product | |
| Table 52. EBEWE Pharma (Sandoz A Novartis Division) Recent Developments | |
| Table 53. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Corporation Information | |
| Table 54. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Description and Major Businesses | |
| Table 55. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 56. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Product | |
| Table 57. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments | |
| Table 58. Mylan Corporation Information | |
| Table 59. Mylan Description and Major Businesses | |
| Table 60. Mylan Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 61. Mylan Vinorelbine Product | |
| Table 62. Mylan Recent Developments | |
| Table 63. Dr. Reddy's Laboratories Corporation Information | |
| Table 64. Dr. Reddy's Laboratories Description and Major Businesses | |
| Table 65. Dr. Reddy's Laboratories Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 66. Dr. Reddy's Laboratories Vinorelbine Product | |
| Table 67. Dr. Reddy's Laboratories Recent Developments | |
| Table 68. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Corporation Information | |
| Table 69. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Description and Major Businesses | |
| Table 70. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 71. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Product | |
| Table 72. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Recent Developments | |
| Table 73. Nanjing Cuccess Pharmaceutical Co., Ltd Corporation Information | |
| Table 74. Nanjing Cuccess Pharmaceutical Co., Ltd Description and Major Businesses | |
| Table 75. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 76. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Product | |
| Table 77. Nanjing Cuccess Pharmaceutical Co., Ltd Recent Developments | |
| Table 78. Qilu Pharmaceutical (Hainan) Co., Ltd. Corporation Information | |
| Table 79. Qilu Pharmaceutical (Hainan) Co., Ltd. Description and Major Businesses | |
| Table 80. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 81. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Product | |
| Table 82. Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments | |
| Table 83. Sinopharm A-Think Pharmaceutical Co., Ltd. Corporation Information | |
| Table 84. Sinopharm A-Think Pharmaceutical Co., Ltd. Description and Major Businesses | |
| Table 85. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 86. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Product | |
| Table 87. Sinopharm A-Think Pharmaceutical Co., Ltd. Recent Developments | |
| Table 88. Beijing SL Pharm Corporation Information | |
| Table 89. Beijing SL Pharm Description and Major Businesses | |
| Table 90. Beijing SL Pharm Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 91. Beijing SL Pharm Vinorelbine Product | |
| Table 92. Beijing SL Pharm Recent Developments | |
| Table 93. Shenzhen Main Luck Pharmaceuticals Inc. Corporation Information | |
| Table 94. Shenzhen Main Luck Pharmaceuticals Inc. Description and Major Businesses | |
| Table 95. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 96. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Product | |
| Table 97. Shenzhen Main Luck Pharmaceuticals Inc. Recent Developments | |
| Table 98. Shanxi Powerdone Pharmaceutics Co., Ltd. Corporation Information | |
| Table 99. Shanxi Powerdone Pharmaceutics Co., Ltd. Description and Major Businesses | |
| Table 100. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 101. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Product | |
| Table 102. Shanxi Powerdone Pharmaceutics Co., Ltd. Recent Developments | |
| Table 103. Luoxin Pharmaceutical Group Co., Ltd. Corporation Information | |
| Table 104. Luoxin Pharmaceutical Group Co., Ltd. Description and Major Businesses | |
| Table 105. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021) | |
| Table 106. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Product | |
| Table 107. Luoxin Pharmaceutical Group Co., Ltd. Recent Developments | |
| Table 108. Vinorelbine Production Capacity (MT) of Key Manufacturers in China Market, 2019-2021 (MT) | |
| Table 109. China Vinorelbine Capacity Market Share of Key Manufacturers, 2019-2021 | |
| Table 110. Vinorelbine Market Opportunities & Trends in China Market | |
| Table 111. Vinorelbine Market Drivers in China Market | |
| Table 112. Vinorelbine Market Restraints in China Market | |
| Table 113. Vinorelbine Raw Materials | |
| Table 114. Vinorelbine Raw Materials Suppliers in China Market | |
| Table 115. Typical Vinorelbine Downstream | |
| Table 116. Vinorelbine Downstream Clients in China Market | |
| Table 117. Vinorelbine Distributors and Sales Agents in China Market | |
| 中國(guó)ビノレルビン市場(chǎng)の詳細(xì)な調(diào)査と傾向分析レポート2022-2027 | |
| List of Figures | |
| Figure 1. Vinorelbine Product Picture | |
| Figure 2. Vinorelbine Segment by Type | |
| Figure 3. Vinorelbine Segment by Application | |
| Figure 4. China Vinorelbine Market Overview: 2020 | |
| Figure 5. China Vinorelbine Market Size: 2021 VS 2027 (US$, Mn) | |
| Figure 6. China Vinorelbine Revenue, 2016-2027 (US$, Mn) | |
| Figure 7. Vinorelbine Sales in China Market: 2016-2027 (MT) | |
| Figure 8. The Top 3 and 5 Players Market Share by Vinorelbine Revenue in 2020 | |
| Figure 9. Oral Product Picture | |
| Figure 10. Injection Product Picture | |
| Figure 11. By Type - China Vinorelbine Sales Market Share, 2016-2027 | |
| Figure 12. By Type - China Vinorelbine Revenue Market Share, 2016-2027 | |
| Figure 13. By Type - China Vinorelbine Price (USD/Kg), 2016-2027 | |
| Figure 14. Breast Cancer | |
| Figure 15. Non-small Cell Lung Cancer | |
| Figure 16. Other | |
| Figure 17. By Application - China Vinorelbine Sales Market Share, 2016-2027 | |
| Figure 18. By Application - China Vinorelbine Revenue Market Share, 2016-2027 | |
| Figure 19. By Application - China Vinorelbine Price (USD/Kg), 2016-2027 | |
| Figure 20. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 21. TEVA Pharms Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 22. Hospira, Inc. Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 23. West-Ward Pharmaceuticals Corp. Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 24. Fresenius Kabi Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 25. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 26. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 27. Mylan Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 28. Dr. Reddy's Laboratories Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 29. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 30. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 31. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 32. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 33. Beijing SL Pharm Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 34. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 35. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 36. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 37. China Vinorelbine Production Capacity (MT), 2016-2027 | |
| Figure 38. Vinorelbine Industry Value Chain | |
| Figure 39. Marketing Channels | |
略……
如需購(gòu)買《China Vinorelbine Market In-Depth Research and Trends Analysis Report 2022-2027》，編號(hào)：3209296
請(qǐng)您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網(wǎng)上訂購(gòu)】 ┊ 下載《訂購(gòu)協(xié)議》 ┊ 了解“訂購(gòu)流程”
請(qǐng)您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網(wǎng)上訂購(gòu)】 ┊ 下載《訂購(gòu)協(xié)議》 ┊ 了解“訂購(gòu)流程”
京公網(wǎng)安備 11010802027365號(hào)